These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12433436)

  • 21. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
    Anroop B; Ghosh B; Parcha V; Khanam J
    Curr Drug Deliv; 2009 Jul; 6(3):280-90. PubMed ID: 19604142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin.
    Sebastiani P; Nicoli S; Santi P
    Int J Pharm; 2005 Mar; 292(1-2):119-26. PubMed ID: 15725558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer.
    Oh SY; Jeong SY; Park TG; Lee JH
    J Control Release; 1998 Feb; 51(2-3):161-8. PubMed ID: 9685913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
    Prasanthi D; Lakshmi PK
    Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of sodium nonivamide propionate by iontophoresis.
    Fang JY; Kuo CT; Huang YB; Wu PC; Tsai YH
    Biol Pharm Bull; 1998 Oct; 21(10):1117-20. PubMed ID: 9821823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
    Nair A; Reddy C; Jacob S
    Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.
    Yan G; Xu Q; Anissimov YG; Hao J; Higuchi WI; Li SK
    Pharm Res; 2008 Mar; 25(3):616-24. PubMed ID: 17703345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
    Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery and stability of LHRH and Nafarelin in human skin: the effect of constant/pulsed iontophoresis.
    Raiman J; Koljonen M; Huikko K; Kostiainen R; Hirvonen J
    Eur J Pharm Sci; 2004 Feb; 21(2-3):371-7. PubMed ID: 14757511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride.
    Bhatia G; Banga AK
    Biomed Res Int; 2014; 2014():537941. PubMed ID: 24959580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response surface method: a novel strategy to optimize iontophoretic transdermal delivery of thyrotropin-releasing hormone.
    Huang YY; Wu SM; Wang CY
    Pharm Res; 1996 Apr; 13(4):547-52. PubMed ID: 8710744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.